The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
November 7, 202326m 30s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
Learn more about your ad choices. Visit megaphone.fm/adchoices